CVS Health (CVS) Tops Q1 EPS by 7c; Confirms Guidance

CVS Health (NYSE: CVS) reported Q1 EPS of $1.17, $0.07 better than the analyst estimate of $1.10. Revenue for the quarter came in at $44.5 billion versus the consensus estimate of $44.2 billion.

• Net revenues increased 3.0% to $44.5 billion
• GAAP diluted EPS from continuing operations of $0.92; Adjusted EPS of $1.17
• Generated cash flow from operations of $3.5 billion; free cash flow of $3.1 billion

GUIDANCE:

CVS Health confirms FY2017 EPS of $5.77-$5.93, versus the consensus of $5.86.

• Confirmed full year GAAP diluted EPS from continuing operations of $5.02 to $5.18
• Confirmed full year Adjusted EPS of $5.77 to $5.93
• Provided second quarter GAAP diluted EPS from continuing operations of $1.15 to $1.19
• Provided second quarter Adjusted EPS of $1.29 to $1.33
• Confirmed full year cash flow from operations of $7.7 to $8.6 billion; free cash flow of $6.0 to $6.4 billion

For earnings history and earnings-related data on CVS Health (CVS) click here.

You May Also Be Interested In

• Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
• Community Trust Bancorp (CTBI) Misses Q3 EPS by 22c
• Barclays cuts Cirrus Logic price target to $95 from $130, cuts to Underweight